Bradykinin B2 Receptor Antagonists
- Name
- Bradykinin B2 Receptor Antagonists
- Accession Number
- DBCAT001770
- Description
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.
- Drugs
Drug Drug Description Icatibant A bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE). Fasitibant Fasitibant is under investigation in clinical trial NCT02205814 (Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee). - Drugs & Drug Targets
Drug Target Type Icatibant B2 bradykinin receptor target Icatibant Aminopeptidase N target